BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos&r...

February 07, 2023 | News

BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...

February 03, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test. Highlights: New test integ...

February 03, 2023 | News

FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis

"With an oral drug option in addition to the FDA-approved injection options, adults with chronic kidney disease on dialysis now have multiple ways to treat...

February 02, 2023 | News

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...

February 02, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

February 01, 2023 | News

Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an Investigational Respiratory Syncytial Virus (Rsv) Vaccine Candidate

 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investig...

January 30, 2023 | News

Lupin Launches LYFE, its Digital Therapeutic Solution for Holistic Heart Care

Designed by leading Indian cardiologists, LYFE helps patients improve their heart health through doctor-connected online and offline modules. FDA and CE ap...

January 27, 2023 | News

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

Zhongxin launched the Program aiming to navigate and solve the medication challenges faced by cancer patients. During cancer treatment process, the use of ...

January 20, 2023 | News

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psyc...

January 17, 2023 | News

No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes

Partnership agreed to miniaturize a non-invasive glucose sensor for your wrist Minilaser-based technology to make life easier for diabetes patients Mor...

January 09, 2023 | News

Montoux Announces Multi-Year Global Strategic Collaboration Agreement with AWS

To help life and health insurers accelerate their strategic modernization and digital transformation initiatives, Montoux Inc. (Montoux), a leading actuari...

January 06, 2023 | News

NuraLogix Announces 'Holy Grail' of Blood Pressure Measurement

"What is the Holy Grail of contactless blood pressure measurement? It's when you can measure your blood pressure with an accuracy corresponding to a standa...

January 05, 2023 | News

Japan Ministry of Health, Labor and Welfare Approves Manufacturing and Marketing of Adtralza® (tralokinumab) in Japan for Adults with Atopic Dermatitis

Approval is a significant advancement for those patients in Japan who continue to suffer from the often-debilitating symptoms of atopic dermatitis and are ...

December 26, 2022 | News

Stay Connected